We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026
20 Aug 2026 - 22 Aug 2026

Aspirin Found To Prevent Liver Damage

By HospiMedica International staff writers
Posted on 18 Feb 2009
Aspirin may prevent liver damage in millions of people suffering from side effects of common drugs, alcohol abuse, and obesity-related liver disease, a new study suggests. More...


The study in the January 26, 2009, issue of Journal of Clinical Investigation revealed that in mice, aspirin reduced mortality caused by an overdose of acetaminophen, mostly known by the brand name Tylenol. It additionally revealed that a class of molecules known as toll-like receptor (TLR) antagonists, which block receptors known to activate inflammation, have a similar effect as aspirin. Since these agents seem to work by reducing injury-induced inflammation, the findings suggest aspirin may help prevent and treat liver damage from a host of noninfectious causes, according to Wajahat Mehal, M.D., from the section of digestive diseases and department of immunobiology at Yale School of Medicine (New Haven, CT, USA).

"Many agents such as drugs and alcohol cause liver damage, and we have found two ways to block a central pathway responsible for such liver injury,” Dr. Mehal said. "Our strategy is to use aspirin on a daily basis to prevent liver injury, but if it occurs, to use TLR antagonists to treat it.”

Potential drugs that have failed clinical trials because of liver toxicity might be revived if combined with aspirin, according to Dr. Mehal. "This offers the exciting possibility of reducing a lot of pain and suffering in patients with liver diseases, using a new and very practical approach,” concluded Dr. Mehal.

Related Links:

Yale School of Medicine




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
New
Radiology Monitor
Barco MDNC-12130 Nio Fusion 12MP Radiology Monitor
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.